"At Actelion, we believe that our success is based on a culture that is in line with modern standards of corporate governance, and on a set of shared values. Acting on these values, we have acknowledged the importance of compliant, ethical and transparent behavior in all aspects of our business. In the interests of transparency and accountability to our shareholders, the principles, activities and rules relating to corporate governance are reviewed by the Board of Directors." Peter Herrmann, Compliance Officer

The overarching principle of Actelion’s Corporate Responsibility reflects the company’s mission to provide innovative medicines for unmet medical needs. To this end, the company has continued to invest heavily in its research and development efforts. During 2010, this investment totaled CHF 484.3 million, which represents 27% of our product sales.

The company is confident that in this way we can deliver the most value to all stakeholders – and most importantly to patients. However, we also understand that it is important to pursue this mission in a responsible, respectful and ethical manner.

In 2009, Actelion took steps to formalize its approach to Corporate Social Responsibility, establishing areas of focus which we are committed to working on. During 2010, we put tools in place to measure and report our progress in realizing the strategy.

Reaching the highest business standards is not possible without a committed workforce. Actelion’s employees are the cornerstone of the company, and their diverse skills and capabilities are highly valued. Providing a safe and ethical workplace, promoting the health and wellbeing of all our people, is a core principle. Such a working environment not only benefits our employees, it supports our business through improved employee engagement, retention and productivity.